USA flag logo/image

An Official Website of the United States Government

A NOVEL, RAPID TEST FOR DIAGNOSIS OF T.CRUZI INFECTION

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
60554
Program Year/Program:
2002 / SBIR
Agency Tracking Number:
AI052683
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2002
Title: A NOVEL, RAPID TEST FOR DIAGNOSIS OF T.CRUZI INFECTION
Agency: HHS
Contract: 1R43AI052683-01
Award Amount: $99,812.00
 

Abstract:

DESCRIPTION (provided by applicant): This proposal is to produce a rapid serodiagnostic and accurate confirmatory test for detection of Trypanosoma cruzi infections built on a novel recombinant antigen. This parasite, transmitted via blood transfusion, is prevalent in Latin America, and the causative agent for fatal Chagas' disease. Positive blood donors have been identified, and transmission via the insect vector has been reported in the U.S.A. Current methods to detect infection involve serological screening using whole parasites, or crude lysates, and confirmation tests in the U.S.A use a complex radioimmunoprecipitation assay. In this proposal we will incorporate a novel recombinant protein TcF that contains four different repeating epitopes with additional known antigens or novel antigens to be identified by serological expression cloning using low titer/RIPA confirmed and TcF low or non-reactive sera from U.S.A. blood donors and from different regions of Central America. This proposal details (1) the development of a rapid, inexpensive test for the diagnosis of T.cruzi infections in small clinics/blood banks in Latin America and (2) a confirmatory assay for use in the U.S.A in diagnosing T. cruzi infections in prospective U.S.A. cardiac surgery patients with high risk factors for Chagas' disease. These studies will exploit the expertise of InBios to develop rapid tests in combination with Corixa TcF antigen. The studies will also benefit from a close collaboration with renowned consultants and collaborators as well as access to their serum banks.

Principal Investigator:

Syamal Raychaudhuri
2063445821
RAYCHAUD@IBIOS.COM

Business Contact:

Estela Figueroa
2063445821
ESTELA@INBIOS.COM
Small Business Information at Submission:

INBIOS INTERNATIONAL, INC.
INBIOS INTERNATIONAL, INC. 562 1ST AVE S, STE 600 SEATTLE, WA 98104

EIN/Tax ID: 911791824
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No